A lot testing protocol for quality assurance of fentanyl test strips for harm reduction applications.

IF 4 2区社会学 Q1 SUBSTANCE ABUSE

Harm Reduction Journal Pub Date : 2024-08-21 DOI:10.1186/s12954-024-01058-y

Hirudini Fernando, Anita Amate, Kathleen L Hayes, Heather D Whitehead, Charlie Desnoyers, Emmanuel Uzobuife, Madison S Denchfield, Braden Whitelatch, Marya Lieberman

引用次数: 0

Abstract

Fentanyl test strips (FTS) are lateral flow immunoassays that were originally designed and validated for detecting low concentrations of fentanyl in urine. Some FTS are now being marketed for the harm reduction purpose of testing street drugs for the presence of fentanyl. This manuscript provides a simple protocol to assess whether different brands and lots of fentanyl test strips perform adequately for use in drug checking. The results gathered from this protocol will document problems with particular lots or brands of FTS, help buyers choose from among the array of products, provide feedback to manufacturers to improve their products, and serve as an early warning system for ineffective products.

查看原文本刊更多论文

用于减低伤害的芬太尼试纸质量保证的批量测试协议。

芬太尼试纸（FTS）是一种横向流动免疫测定法，最初是为检测尿液中低浓度的芬太尼而设计和验证的。目前，一些 FTS 正在市场上销售，用于检测街头毒品中是否含有芬太尼，以达到减少危害的目的。本手稿提供了一个简单的方案，用于评估不同品牌和批次的芬太尼检测试纸在毒品检查中的性能是否足够。从该规程中收集的结果将记录特定批次或品牌的芬太尼试纸存在的问题，帮助购买者从一系列产品中进行选择，为制造商提供反馈以改进其产品，并作为无效产品的预警系统。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Harm Reduction Journal Medicine-Public Health, Environmental and Occupational Health

CiteScore

5.90

自引率

9.10%

发文量

126

审稿时长

26 weeks

期刊介绍： Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.